This analysis confirmed that ATOX1 mRNA levels are generally increased in the cancers with the most significant upregulation in DLBC, liver hepatocellular carcinoma, ovarian serous cystadenocarcinoma, skin cutaneous melanoma, pancreatic adenocarcinoma, thymoma, and uterine carcinosarcoma (Fig. 4a). Here, ATOX1 is linked to pancreatic adenocarcinoma.